Evertogen Life Sciences Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2013.
2013 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Evertogen Life Sciences Limited

Evertogen Life Sciences Limited, a active public limited company, was established on 11 January 2013 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2013PLC085349. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹122.00 Cr and a paid-up capital of ₹119.14 Cr.

Formerly known as Optimus Generics Limited. It upholds a compliant status. Employing 265 professional, Its leadership includes Manav Jassal (Director), Subbarao Kattamuri (Managing Director), Sherifuddin Sheriff Shaik (Director). Past directors included Saritha Rani Premraj, Arun Prakash, Subbarao Kattamuri. It holds ₹135.17 Cr open charges and ₹36.51 Cr settled loans. Its latest AGM occurred on 09 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2013PLC085349

  • Registration Number

    085349

  • Incorporation Date

    11 January 2013

  • Authorized Capital

    ₹122.00 Cr

  • Paid-Up Capital

    ₹119.14 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 122.00 Cr
  • Paid Up Capital ₹ 119.14 Cr
  • Company Age 13 Year, 30 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 135.17 Cr
  • Satisfied Charges ₹ 36.51 Cr
  • Revenue Growth **** 54.51%
  • Profit Growth **** 39.63%
  • Ebitda **** 63.74%
  • Net Worth -119.66%
  • Total Assets **** 1.72%
Company report

Evertogen Life Sciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Evertogen Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Evertogen Life Sciences Limited?
Current Directors
Name Designation Appointment Date Status
Manav Jassal Director 11 Jan 2013 Current
Subbarao Kattamuri Managing Director 11 Jan 2013 Current
Sherifuddin Sheriff Shaik Director 06 Dec 2023 Current
Vikram Ravindra Mamidipudi Director 27 Mar 2015 Current
Sushma Kattamuri Director 05 Jan 2022 Current
Sat Paul Jassal Director 18 Jun 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 31 Aug 2020 Past
Pramod Abcsdd Director 20 Jul 2020 Past
Pramod Abcsdd Director 09 Feb 2013 Past
Pramod Abcsdd Ceo(Kmp) - Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Chief Financial Officer - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Evertogen Life Sciences.

Evertogen Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.51% increase. The company also saw a substantial improvement in profitability, with a 39.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 119.66%.

Evertogen Life Sciences revenue growth over time
Evertogen Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 54.51%
*******
*******
*******
*******
Revenue from Operations
*******
 54.45%
*******
*******
*******
*******
Total Assets
*******
 1.72%
*******
*******
*******
*******
Profit or Loss
*******
 39.63%
*******
*******
*******
*******
Net Worth
*******
 -119.66%
*******
*******
*******
*******
EBITDA
*******
 63.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Evertogen Life Sciences?

In 2023, Evertogen Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,351,704,043.00

Satisfied Charges

₹365,117,638.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 95.00 Cr
  • Hdfc Bank Limited : 37.30 Cr
  • Others : 2.87 Cr
Latest Charge Details
Date Lender Amount Status
18 Apr 2022 Hdfc Bank Limited ₹37.30 Cr Open
16 Sep 2020 Axis Bank Limited ₹5.20 Cr Open
25 Aug 2020 Others ₹2.87 Cr Open
07 Feb 2014 Axis Bank Limited ₹89.80 Cr Open
29 Mar 2022 Others ₹20.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Evertogen Life Sciences?

Evertogen Life Sciences has a workforce of 265 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Evertogen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evertogen Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Evertogen Life Sciences
Recent Activity within the Organization
  • Director Appointment

    Progress on Akhila Thotapally was appointed as a Company Secretary was appointed as a Company Secretary on 22 Jul 2025 & has been associated with this company since 6 months 22 days . was documented.

  • Charges

    A charge registered on 29 Mar 2022 via Charge ID 100573842 with Others was fully satisfied on 01 Oct 2024. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 37.30 Cr registered on 18 Apr 2022 with Charge ID 100568530 was modified on 23 Sep 2024. was recorded as a recent event.

  • Annual General Meeting

    Evertogen Life Sciences Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Evertogen Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Sherifuddin Sheriff Shaik was appointed as a Director was appointed as a Director on 06 Dec 2023 & has been associated with this company since 2 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Evertogen Life Sciences Limited?

The CIN of Evertogen Life Sciences Limited is U24232TG2013PLC085349.

Where is Evertogen Life Sciences Limited headquartered?

Evertogen Life Sciences Limited is headquartered at 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, 500018.

When was Evertogen Life Sciences Limited incorporated?

Evertogen Life Sciences Limited was incorporated on 11 January 2013.

Who are the current directors of Evertogen Life Sciences Limited?

The current directors of Evertogen Life Sciences Limited are

What is the primary industry of Evertogen Life Sciences Limited?

The primary industry of Evertogen Life Sciences Limited is Manufacturing.

Is Evertogen Life Sciences Limited a listed company?

Evertogen Life Sciences Limited is unlisted.

What is the capital structure of Evertogen Life Sciences Limited?

The authorized capital of Evertogen Life Sciences Limited is ₹122.00 Cr, and the paid-up capital is ₹119.14 Cr.

What is the compliance status of Evertogen Life Sciences Limited?

The compliance status of Evertogen Life Sciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available